• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】40806

【品名】6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one

【CA登记号】

【 分 子 式 】C6H6N4O

【 分 子 量 】150.14

【元素组成】C 48% H 4.03% N 37.32% O 10.66%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(X)

4-Methyl-5-nitroimidazole (I) is condensed with benzaldehyde (II) in the presence of piperidine to produce the 4-styryl imidazole (III). Alkylation of imidazole (III) with benzyl chloride leads to a 3:1 mixture of regioisomeric N-benzyl imidazoles (IV) and (V). Ozonolysis of this mixture, followed by oxidative work-up of the ozonide with performic acid, allows isolation of the desired imidazolecarboxylic acid (VI) by employing a differential precipitation technique. Activation of acid (VI) with CDI, and further treatment of the resultant imidazolide with potassium methanenitronate gives rise to nitro ketone (VII). Both nitro groups of (VII) are then reduced by SnCl2 in concentrated HCl to furnish diamine (VIII). Then, removal of the N-benzyl group of (VIII) by catalytic hydrogenation over Pd/C yields imidazole (IX). Ring closure of (IX) in the presence of triethyl orthoformate produces the imidazodiazepinone (X)

1 Chan, E.; et al.; Total synthesis of (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (pentostatin), the potent inhibitor of adenosine deaminase. J Org Chem 1982, 47, 18, 3457.
2 Baker, D.C.; Putt, S.R.; A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase. J Am Chem Soc 1979, 101, 20, 6127.
3 Baker, D.C.; Putt, S.R. (Pfizer Inc.); 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation. DE 2835144; ES 472478; ES 479618; GB 2005661; GB 2013680; US 4117229 .
4 Baker, D.C.; Putt, S.R. (Pfizer Inc.); Imidazole cpds., methods for their production and conversion of said cpds. into (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol. US 4195176 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 62513 4-methyl-5-nitro-1H-imidazole C4H5N3O2 详情 详情
(II) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(III) 62514 5-nitro-4-[(E)-2-phenylethenyl]-1H-imidazole C11H9N3O2 详情 详情
(IV) 62515 1-benzyl-4-nitro-5-[(E)-2-phenylethenyl]-1H-imidazole C18H15N3O2 详情 详情
(V) 62516 1-benzyl-5-nitro-4-[(E)-2-phenylethenyl]-1H-imidazole C18H15N3O2 详情 详情
(VI) 62517 1-benzyl-4-nitro-1H-imidazole-5-carboxylic acid C11H9N3O4 详情 详情
(VII) 62518 1-(1-benzyl-4-nitro-1H-imidazol-5-yl)-2-nitro-1-ethanone C12H10N4O5 详情 详情
(VIII) 62519 2-amino-1-(4-amino-1-benzyl-1H-imidazol-5-yl)-1-ethanone C12H14N4O 详情 详情
(IX) 62520 2-amino-1-(5-amino-1H-imidazol-4-yl)-1-ethanone C5H8N4O 详情 详情
(X) 40806 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one C6H6N4O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(X)

After silylation of the imidazodiazepinone (X) employing bis(trimethylsilyl)trifluoroacetamide, glycosylation with 2-deoxy-3,5-di-p-toluoyl-D-erythro-pentofuranosyl chloride (XI) leads to a mixture of glycoside anomers (XII) and (XIII), from which the desired beta-anomer (XII) can be isolated by either column chromatography or by fractional crystallization. The toluoyl ester groups of (XII) are then removed by methanolysis in the presence of NaOMe to afford (XIV). Finally, reduction of ketone (XIV) gives rise to a 60:40 mixture of the target (R)-hydroxy imidazodiazepine along with its (S)-epimer (XV), which are separated by reverse-phase preparative HPLC

1 Baker, D.C.; Putt, S.R.; A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase. J Am Chem Soc 1979, 101, 20, 6127.
2 Chan, E.; et al.; Total synthesis of (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (pentostatin), the potent inhibitor of adenosine deaminase. J Org Chem 1982, 47, 18, 3457.
3 Baker, D.C.; Putt, S.R. (Pfizer Inc.); Imidazole cpds., methods for their production and conversion of said cpds. into (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol. US 4195176 .
4 Baker, D.C.; Putt, S.R. (Pfizer Inc.); 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation. DE 2835144; ES 472478; ES 479618; GB 2005661; GB 2013680; US 4117229 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(X) 40806 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one C6H6N4O 详情 详情
(XI) 37194 (2R,3S)-5-Chloro-2-[[(4-methylbenzoyl)oxy]methyl]tetrahydro-3-furanyl 4-methylbenzoate 4330-21-6 C21H21ClO5 详情 详情
(XII) 62522 {(2R,3S,5R)-3-[(4-methylbenzoyl)oxy]-5-[8-oxo-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]tetrahydro-2-furanyl}methyl 4-methylbenzoate C27H26N4O6 详情 详情
(XIII) 62521 {(2R,3S,5S)-3-[(4-methylbenzoyl)oxy]-5-[8-oxo-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]tetrahydro-2-furanyl}methyl 4-methylbenzoate C27H26N4O6 详情 详情
(XIV) 62523 3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one C11H14N4O4 详情 详情
(XV) 62524 (8S)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol C11H16N4O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VI)

Dibenzyl malonate (I) was alkylated with 3-(trifluoromethyl)benzyl bromide (II) in the presence of Na in DMF to yield the 3-(trifluoromethyl)benzylmalonate (III). Further alkylation of (III) with 1,4-dibromobutane (IV) provided the bromobutyl derivative (V). Condensation of the known 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8-one (VI) with bromide (V) in the presence of NaH and NaI furnished adduct (VII). The keto group of (VII) was then reduced to alcohol (VIII) employing NaBH4 in MeOH-CH2Cl2. Finally, hydrogenolysis of the benzyl ester groups of (VIII) in the presence of Pd/C and Et3N afforded the title dicarboxylate triethylammonium salt.

1 Bookser, B.C.; Kasibhatla, S.R.; Erion, M.D.; AMP deaminase inhibitors. 4. Further N3-substituted coformycin aglycon analogues: N3-alkylmalonates as ribose 5'-monophosphate mimetics. J Med Chem 2000, 43, 8, 1519.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16013 dibenzyl malonate 15014-25-2 C17H16O4 详情 详情
(II) 40803 1-(bromomethyl)-3-(trifluoromethyl)benzene 402-23-3 C8H6BrF3 详情 详情
(III) 40804 dibenzyl 2-[3-(trifluoromethyl)benzyl]malonate C25H21F3O4 详情 详情
(IV) 11883 1,4-Dibromobutane; 1,4-Butylene bromide 110-52-1 C4H8Br2 详情 详情
(V) 40805 dibenzyl 2-(4-bromobutyl)-2-[3-(trifluoromethyl)benzyl]malonate C29H28BrF3O4 详情 详情
(VI) 40806 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one C6H6N4O 详情 详情
(VII) 40807 dibenzyl 2-[4-[8-oxo-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]butyl]-2-[3-(trifluoromethyl)benzyl]malonate C35H33F3N4O5 详情 详情
(VIII) 40808 dibenzyl 2-[4-[8-hydroxy-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]butyl]-2-[3-(trifluoromethyl)benzyl]malonate C35H35F3N4O5 详情 详情
Extended Information